Gossamer Bio, Inc. (GOSS) Financials

GOSS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 311.9 million 249.1 million
2023-09-30 347.9 million 243.3 million
2023-06-30 181.7 million 244.5 million
2023-03-31 219.9 million 248.4 million

GOSS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -33.4 million 6.0 million
2023-09-30 -34.5 million 6.2 million
2023-06-30 -38.3 million 8.2 million
2023-03-31 -53.0 million 8.1 million

GOSS Net Income

No data available :(

GOSS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 296.4 million - 3.4 million
2023-09-30 328.9 million - 4.2 million
2023-06-30 162.1 million - 5.0 million
2023-03-31 201.9 million - 5.7 million

GOSS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 225.4 million
2023-09-30 192.9 million
2023-06-30 95.4 million
2023-03-31 94.9 million

GOSS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 29.7 million 9.1 million 714000
2023-09-30 30000 31.2 million 9.3 million -
2023-06-30 15000 36.3 million 10.0 million -
2023-03-31 15000 37.8 million 10.1 million -

GOSS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 1.0 million
2023-09-30 - 1.1 million
2023-06-30 - 1.2 million
2023-03-31 - 1.1 million

GOSS

Price: $0.67

52 week price:
0.45
1.88

Earnings Per Share: -1.18 USD

P/E Ratio: -0.54

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 916653

Market Capitalization: 203.2 million

Links: